| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-08 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |